Business Context and Reporting Period
This Form 8-K Current Report was filed by Ellington Financial Inc. on October 20, 2023. The filing discloses the entry into a material definitive agreement involving a registered direct offering of securities.
Key Financial Metrics
The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, margins, or debt levels for Ellington Financial Inc. The primary financial data relates to a specific transaction:
- Transaction Type: Purchase of common stock in Great Ajax Corp.
- Shares Acquired: 1,666,666 shares.
- Purchase Price: $6.60 per share.
- Total Investment: Approximately $11.0 million (gross proceeds to Great Ajax).
Material Changes
On October 20, 2023, Ellington Financial Inc. entered into a Securities Purchase Agreement with Great Ajax Corp. This agreement represents a new investment position for Ellington Financial in Great Ajax Corp. via a registered direct offering. No comparative financial data or changes to prior periods are provided in this specific filing.
Guidance, Outlook, and Risks
The filing contains standard forward-looking statements regarding the transaction and general business operations. It explicitly states that actual results may differ materially from anticipated results due to various risks and uncertainties. The document refers investors to the "Risk Factors" section of the Company's most recent Annual Report on Form 10-K and Quarterly Reports on Form 10-Q for a comprehensive list of potential risks. No specific guidance or outlook regarding future earnings or capital allocation beyond this transaction is provided.
Investor Verification Checklist
- Verify the full text of the Securities Purchase Agreement filed as Exhibit 10.1 for specific covenants and representations.
- Review Great Ajax Corp.'s shelf registration statement (File No. 333-240999) and the prospectus supplement dated October 20, 2023.
- Consult Ellington Financial Inc.'s most recent Form 10-K and 10-Q for detailed risk factors and overall financial health.
- Confirm the impact of this $11.0 million investment on Ellington Financial's current liquidity and portfolio concentration.